{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:43:29Z","timestamp":1790739809553,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007202","name":"Gouvernement du Canada | Instituts de Recherche en Sant\u00e9 du Canada | CIHR Skin Research Training Centre","doi-asserted-by":"publisher","award":["GSD-157948"],"award-info":[{"award-number":["GSD-157948"]}],"id":[{"id":"10.13039\/501100007202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1038\/s41386-019-0561-y","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T14:03:34Z","timestamp":1572876214000},"page":"925-931","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Replicating predictive serum correlates of greater translocator protein distribution volume in brain"],"prefix":"10.1038","volume":"45","author":[{"given":"Sophia","family":"Attwells","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Setiawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan A.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo M.","family":"Rusjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Miler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad I.","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Kish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Vasdev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Houle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey H.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,4]]},"reference":[{"key":"561_CR1","unstructured":"WHO. 169 (World Health Organization, Geneva, Switzerland, 2001)."},{"key":"561_CR2","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1001\/jamapsychiatry.2017.1567","volume":"74","author":"S Attwells","year":"2017","unstructured":"Attwells S, Setiawan E, Wilson AA, Rusjan PM, Mizrahi R, Miler L, et al. Inflammation in the neurocircuitry of obsessive-compulsive disorder. JAMA Psychiatry. 2017;74:833\u201340.","journal-title":"JAMA Psychiatry"},{"key":"561_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S2215-0366(18)30048-8","volume":"5","author":"E Setiawan","year":"2018","unstructured":"Setiawan E, Attwells S, Wilson AA, Mizrahi R, Rusjan PM, Miler L, et al. Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study. Lancet Psychiatry. 2018;5:339\u201347.","journal-title":"Lancet Psychiatry"},{"key":"561_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-018-0401-9","volume":"8","author":"EM Richards","year":"2018","unstructured":"Richards EM, Zanotti-Fregonara P, Fujita M, Newman L, Farmer C, Ballard ED, et al. PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects. EJNMMI Res. 2018;8:57.","journal-title":"EJNMMI Res"},{"key":"561_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pnpbp.2017.12.011","volume":"83","author":"H Li","year":"2018","unstructured":"Li H, Sagar AP, Keri S. Translocator protein (18kDa TSPO) binding, a marker of microglia, is reduced in major depression during cognitive-behavioral therapy. Prog neuro-Psychopharmacol Biol Psychiatry 2018;83:1\u20137.","journal-title":"Prog neuro-Psychopharmacol Biol Psychiatry"},{"key":"561_CR6","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","volume":"21","author":"S Hickman","year":"2018","unstructured":"Hickman S, Izzy S, Sen P, Morsett L, El Khoury J. Microglia in neurodegeneration. Nat Neurosci 2018;21:1359\u201369.","journal-title":"Nat Neurosci"},{"key":"561_CR7","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1001\/jamapsychiatry.2014.2427","volume":"72","author":"E Setiawan","year":"2015","unstructured":"Setiawan E, Wilson AA, Mizrahi R, Rusjan PM, Miler L, Rajkowska G, et al. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry. 2015;72:268\u201375.","journal-title":"JAMA Psychiatry"},{"key":"561_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.biopsych.2017.08.005","volume":"83","author":"SE Holmes","year":"2018","unstructured":"Holmes SE, Hinz R, Conen S, Gregory CJ, Matthews JC, Anton-Rodriguez JM, et al. Elevated translocator protein in anterior cingulate in major depression and a role for inflammation in suicidal thinking: a positron emission tomography study. Biol Psychiatry 2018;83:61\u20139.","journal-title":"Biol Psychiatry"},{"key":"561_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007;8:57\u201369.","journal-title":"Nat Rev Neurosci"},{"key":"561_CR10","doi-asserted-by":"publisher","first-page":"pii: E2707","DOI":"10.3390\/ijms19092707","volume":"19","author":"C Betlazar","year":"2018","unstructured":"Betlazar C, Harrison-Brown M, Middleton RJ, Banati R, Liu GJ. Cellular sources and regional variations in the expression of the neuroinflammatory marker translocator protein (TSPO) in the normal brain. Int J Mol Sci. 2018;19:pii: E2707.","journal-title":"Int J Mol Sci"},{"key":"561_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1023\/A:1018567510105","volume":"26","author":"RB Banati","year":"1997","unstructured":"Banati RB, Myers R, Kreutzberg GW. PK (\u2018peripheral benzodiazepine\u2019)\u2013binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK11195 binding to activated microglia. J Neurocytol. 1997;26:77\u201382.","journal-title":"J Neurocytol"},{"key":"561_CR12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/jcbfm.2009.205","volume":"30","author":"A Martin","year":"2010","unstructured":"Martin A, Boisgard R, Theze B, Van Camp N, Kuhnast B, Damont A, et al. Evaluation of the PBR\/TSPO radioligand [(18)F]DPA-714 in a rat model of focal cerebral ischemia. J Cereb Blood Flow Metab: Off J Int Soc Cereb Blood Flow Metab. 2010;30:230\u201341.","journal-title":"J Cereb Blood Flow Metab: Off J Int Soc Cereb Blood Flow Metab"},{"key":"561_CR13","doi-asserted-by":"publisher","first-page":"153601211879231","DOI":"10.1177\/1536012118792317","volume":"17","author":"V Narayanaswami","year":"2018","unstructured":"Narayanaswami V, Dahl K, Bernard-Gauthier V, Josephson L, Cumming P, Vasdev N. Emerging PET radiotracers and targets for imaging of neuroinflammation in neurodegenerative diseases: outlook beyond TSPO. Mol imaging 2018;17:1536012118792317.","journal-title":"Mol imaging"},{"key":"561_CR14","doi-asserted-by":"crossref","unstructured":"Horti AG, Naik R, Foss CA, Minn I, Misheneva V, Du Y, et al. PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R). Proceedings of the National Academy of Sciences of the United States of America. 2019.","DOI":"10.1073\/pnas.1812155116"},{"key":"561_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2217\/bmm.09.89","volume":"4","author":"D Galasko","year":"2010","unstructured":"Galasko D, Montine TJ. Biomarkers of oxidative damage and inflammation in Alzheimer\u2019s disease. Biomark Med. 2010;4:27\u201336.","journal-title":"Biomark Med"},{"key":"561_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/schbul\/sbx035","volume":"44","author":"AK Wang","year":"2018","unstructured":"Wang AK, Miller BJ. Meta-analysis of cerebrospinal fluid cytokine and tryptophan catabolite alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder, and depression. Schizophrenia Bull 2018;44:75\u201383.","journal-title":"Schizophrenia Bull"},{"key":"561_CR17","first-page":"pii: 226","volume":"5","author":"B Pulli","year":"2014","unstructured":"Pulli B, Chen JW. Imaging neuroinflammation - from bench to bedside. J Clin Cell Immunol. 2014;5:pii: 226.","journal-title":"J Clin Cell Immunol"},{"key":"561_CR18","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/j.1460-9568.1997.tb01444.x","volume":"9","author":"L Minghetti","year":"1997","unstructured":"Minghetti L, Polazzi E, Nicolini A, Creminon C, Levi G. Up-regulation of cyclooxygenase-2 expression in cultured microglia by prostaglandin E2, cyclic AMP and non-steroidal anti-inflammatory drugs. Eur J Neurosci. 1997;9:934\u201340.","journal-title":"Eur J Neurosci"},{"key":"561_CR19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2133\/dmpk.DMPK-14-RG-004","volume":"29","author":"S Akanuma","year":"2014","unstructured":"Akanuma S, Higuchi T, Higashi H, Ozeki G, Tachikawa M, Kubo Y, et al. Transporter-mediated prostaglandin E(2) elimination across the rat blood-brain barrier and its attenuation by the activation of N-methyl-D-aspartate receptors. Drug Metab pharmacokinetics. 2014;29:387\u201393.","journal-title":"Drug Metab pharmacokinetics"},{"key":"561_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/bs.apha.2014.06.006","volume":"71","author":"M Tachikawa","year":"2014","unstructured":"Tachikawa M, Hosoya K, Terasaki T. Pharmacological significance of prostaglandin E2 and D2 transport at the brain barriers. Adv Pharm. 2014;71:337\u201360.","journal-title":"Adv Pharm"},{"key":"561_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2014.08.007","volume":"44","author":"WA Banks","year":"2015","unstructured":"Banks WA. The blood-brain barrier in neuroimmunology: tales of separation and assimilation. Brain Behav Immun. 2015;44:1\u20138.","journal-title":"Brain Behav Immun"},{"key":"561_CR22","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1161\/01.STR.8.6.672","volume":"8","author":"AA Hagen","year":"1977","unstructured":"Hagen AA, Gerber JN, Sweeley CC, White RP, Robertson JT. Levels and disappearance of prostaglandin F2alpha in cerebral spinal fluid: a clinical and experimental study. Stroke 1977;8:672\u20135.","journal-title":"Stroke"},{"key":"561_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4049\/jimmunol.1101029","volume":"188","author":"P Kalinski","year":"2012","unstructured":"Kalinski P. Regulation of immune responses by prostaglandin E2. J Immunol 2012;188:21\u20138.","journal-title":"J Immunol"},{"key":"561_CR24","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/nn1944","volume":"10","author":"KJ Ressler","year":"2007","unstructured":"Ressler KJ, Mayberg HS. Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci 2007;10:1116\u201324.","journal-title":"Nat Neurosci"},{"key":"561_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00429-008-0189-x","volume":"213","author":"WC Drevets","year":"2008","unstructured":"Drevets WC, Price JL, Furey ML. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct. 2008;213:93\u2013118.","journal-title":"Brain Struct Funct"},{"key":"561_CR26","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S2215-0366(15)00579-9","volume":"3","author":"LM Williams","year":"2016","unstructured":"Williams LM. Precision psychiatry: a neural circuit taxonomy for depression and anxiety. Lancet Psychiatry. 2016;3:472\u201380.","journal-title":"Lancet Psychiatry"},{"key":"561_CR27","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1017\/S1461145705005055","volume":"8","author":"KH Adams","year":"2005","unstructured":"Adams KH, Hansen ES, Pinborg LH, Hasselbalch SG, Svarer C, Holm S, et al. Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei. Int J Neuropsychopharmacol. 2005;8:391\u2013401.","journal-title":"Int J Neuropsychopharmacol"},{"key":"561_CR28","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/sj.npp.1301528","volume":"33","author":"DF Wong","year":"2008","unstructured":"Wong DF, Brasic JR, Singer HS, Schretlen DJ, Kuwabara H, Zhou Y, et al. Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. Neuropsychopharmacology. 2008;33:1239\u201351.","journal-title":"Neuropsychopharmacology"},{"key":"561_CR29","unstructured":"Saxena S, Brody AL, Schwartz JM, Baxter LR. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br. J. Psychiatry. 1998;35:26\u201337."},{"key":"561_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"561_CR31","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1001\/archpsyc.1989.01810110054008","volume":"46","author":"WK Goodman","year":"1989","unstructured":"Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, et al. The yale-brown obsessive compulsive scale. II. Validity. Arch Gen Psychiatry. 1989;46:1012\u20136.","journal-title":"Arch Gen Psychiatry"},{"key":"561_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pscychresns.2006.01.011","volume":"147","author":"P Rusjan","year":"2006","unstructured":"Rusjan P, Mamo D, Ginovart N, Hussey D, Vitcu I, Yasuno F, et al. An automated method for the extraction of regional data from PET images. Psychiatry Res. 2006;147:79\u201389.","journal-title":"Psychiatry Res."},{"key":"561_CR33","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1038\/jcbfm.2011.55","volume":"31","author":"PM Rusjan","year":"2011","unstructured":"Rusjan PM, Wilson AA, Bloomfield PM, Vitcu I, Meyer JH, Houle S, et al. Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomography. J Cereb Blood Flow Metab. 2011;31:1807\u201316.","journal-title":"J Cereb Blood Flow Metab"},{"key":"561_CR34","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/82219","volume":"6","author":"B Kwak","year":"2000","unstructured":"Kwak B, Mulhaupt F, Myit S, Mach F. Statins as a newly recognized type of immunomodulator. Nat Med. 2000;6:1399\u2013402.","journal-title":"Nat Med."},{"key":"561_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-5-15","volume":"5","author":"CJ Henry","year":"2008","unstructured":"Henry CJ, Huang Y, Wynne A, Hanke M, Himler J, Bailey MT, et al. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J Neuroinflammation. 2008;5:15.","journal-title":"J Neuroinflammation"},{"key":"561_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.40","volume":"6","author":"JM Coughlin","year":"2016","unstructured":"Coughlin JM, Wang Y, Ambinder EB, Ward RE, Minn I, Vranesic M, et al. In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [(11)C]DPA-713 PET and analysis of CSF and plasma. Transl Psychiatry. 2016;6:e777.","journal-title":"Transl Psychiatry"},{"key":"561_CR37","doi-asserted-by":"publisher","first-page":"12468","DOI":"10.1073\/pnas.1511003112","volume":"112","author":"CM Sandiego","year":"2015","unstructured":"Sandiego CM, Gallezot JD, Pittman B, Nabulsi N, Lim K, Lin SF, et al. Imaging robust microglial activation after lipopolysaccharide administration in humans with PET. Proc Natl Acad Sci USA. 2015;112:12468\u201373.","journal-title":"Proc Natl Acad Sci USA"},{"key":"561_CR38","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bbi.2013.06.010","volume":"33","author":"J Hannestad","year":"2013","unstructured":"Hannestad J, DellaGioia N, Gallezot JD, Lim K, Nabulsi N, Esterlis I, et al. The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: a [(1)(1)C]PBR28 PET study. Brain Behav Immun. 2013;33:131\u20138.","journal-title":"Brain Behav Immun"},{"key":"561_CR39","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1111\/j.1476-5381.2010.00811.x","volume":"160","author":"O Saito","year":"2010","unstructured":"Saito O, Svensson CI, Buczynski MW, Wegner K, Hua XY, Codeluppi S, et al. Spinal glial TLR4-mediated nociception and production of prostaglandin E(2) and TNF. Br J Pharmacol. 2010;160:1754\u201364.","journal-title":"Br J Pharmacol"},{"key":"561_CR40","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/glia.1107","volume":"36","author":"Y Dong","year":"2001","unstructured":"Dong Y, Benveniste EN. Immune function of astrocytes. Glia 2001;36:180\u201390.","journal-title":"Glia"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41386-019-0561-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-019-0561-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-019-0561-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:07:34Z","timestamp":1684616854000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-019-0561-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,4]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["561"],"URL":"https:\/\/doi.org\/10.1038\/s41386-019-0561-y","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,4]]},"assertion":[{"value":"25 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}